Summary
Machine-generated summaryThe University of Edinburgh awarded a contract for a genome plasmid. The plasmid is to be produced to FDA, IND ready standard for use in manufacturing a lentiviral vector for a clinical trial treating a rare genetic disease that causes progressive dementia in children. The therapy uses autologous haematopoietic stem progenitor cells modified ex vivo with a lentiviral vector to express a secreted enzyme in myeloid progeny, delivering enzyme to the central nervous system. The plasmid will be delivered directly from the supplier to the University of California Los Angeles, the University of Edinburgh's partner in the project. Indiana University won the contract, awarded on 2025-08-14.
Description
Official source
Source: Public Contracts Scotland
Always verify details on the official notice.
Last verified against Public Contracts Scotland 1 day ago
More from this buyer
Full buyer profile4 open tenders right now
- ACE Contract Cleaning Services 3 days left
- Non-Torque Loading System for Electrical Machine Testing Including Drive System 10 days left
- Window Cleaning Services 24 days left
Recent awards
Similar tenders
10
days left
€2,711,686
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €9,471,566
- Buyer track record on Aperlena
- 143 notices tracked · 129 awarded
- €107,335,090 in awarded contracts
Never miss a tender like this
115 new notices in Medical equipment & pharmaceuticals in United Kingdom in the last 7 days. Get an email when new ones appear. Free.
Set up my alert